Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera - PubMed (original) (raw)
Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera
Nicolas Chignard et al. Gastroenterology. 2006 Jun.
Abstract
Background & aims: In the past decade, there has been a rising incidence of hepatocellular carcinoma (HCC) and a progressive increase in HCC-related mortality in the United States and Western Europe. The poor survival of patients with HCC is largely related to the lack of reliable tools for early diagnosis.
Methods: We have applied proteomics tools to the comparative analysis of protein profiles between HCC and adjacent nontumor tissues as a means for discovering novel molecular markers.
Results: Forty-seven protein spots that showed reproducible variation were identified by mass spectrometry, corresponding to 23 distinct genes. A positive correlation between transcript and protein level variations was observed for only 7 out of the 23 genes. Proteolytic cleavage accounted for the discrepancies between messenger RNA and protein level changes for 7 genes including calreticulin, PDIA3, PDI, and GRP78. We detected a fragment of each of these 4 endoplasmic reticulum proteins in the culture supernatant of the PLC-PRF5 hepatoma cell line, suggesting that their cleavage leads to release of selected cleaved products in the extracellular compartment. We also detected calreticulin and PDIA3 cleavage products in sera of patients with HCC. A statistically highly significant difference in calreticulin and PDIA3 fragment serum levels between patients with HCC and healthy individuals was observed. Amounts of calreticulin and PDIA3 fragments were also significantly different between patients with HCC and at-risk patients (patients with chronic hepatitis or cirrhosis).
Conclusions: Specific isoforms in general and cleavage products in particular should therefore be further evaluated as new markers for HCC.
Similar articles
- Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN, Chen CH, Sheu JC, Lee HS, Huang GT, Yu CY, Lu FJ, Chow LP. Lee IN, et al. J Proteome Res. 2005 Nov-Dec;4(6):2062-9. doi: 10.1021/pr0502018. J Proteome Res. 2005. PMID: 16335951 - Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
Luk JM, Lam CT, Siu AF, Lam BY, Ng IO, Hu MY, Che CM, Fan ST. Luk JM, et al. Proteomics. 2006 Feb;6(3):1049-57. doi: 10.1002/pmic.200500306. Proteomics. 2006. PMID: 16400691 - Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
Long J, Lang ZW, Wang HG, Wang TL, Wang BE, Liu SQ. Long J, et al. Hepatobiliary Pancreat Dis Int. 2010 Jun;9(3):296-305. Hepatobiliary Pancreat Dis Int. 2010. PMID: 20525558 - Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
El-Aneed A, Banoub J. El-Aneed A, et al. Anticancer Res. 2006 Sep-Oct;26(5A):3293-300. Anticancer Res. 2006. PMID: 17094443 Review. - High-dimensional biology to comprehend hepatocellular carcinoma.
Vivekanandan P, Singh OV. Vivekanandan P, et al. Expert Rev Proteomics. 2008 Feb;5(1):45-60. doi: 10.1586/14789450.5.1.45. Expert Rev Proteomics. 2008. PMID: 18282123 Review.
Cited by
- Single-cell analysis identified PDIA3 as regulator of malignant characteristics and macrophage function in human cancers.
Wu W, Peng G, Wang K, Yang Y, Liu Z, Xiao G. Wu W, et al. Funct Integr Genomics. 2024 Aug 13;24(4):136. doi: 10.1007/s10142-024-01416-w. Funct Integr Genomics. 2024. PMID: 39138692 - Calreticulin as a potential diagnostic biomarker for lung cancer.
Liu R, Gong J, Chen J, Li Q, Song C, Zhang J, Li Y, Liu Z, Dong Y, Chen L, Jin B. Liu R, et al. Cancer Immunol Immunother. 2012 Jun;61(6):855-64. doi: 10.1007/s00262-011-1146-8. Epub 2011 Nov 15. Cancer Immunol Immunother. 2012. PMID: 22083347 Free PMC article. - A novel prognostic factor for hepatocellular carcinoma: protein disulfide isomerase.
Yu SJ, Won JK, Ryu HS, Choi WM, Cho H, Cho EJ, Lee JH, Kim YJ, Suh KS, Jang JJ, Kim CY, Lee HS, Yoon JH, Cho KH. Yu SJ, et al. Korean J Intern Med. 2014 Sep;29(5):580-7. doi: 10.3904/kjim.2014.29.5.580. Epub 2014 Aug 28. Korean J Intern Med. 2014. PMID: 25228833 Free PMC article. - Increased expression of PDIA3 and its association with cancer cell proliferation and poor prognosis in hepatocellular carcinoma.
Takata H, Kudo M, Yamamoto T, Ueda J, Ishino K, Peng WX, Wada R, Taniai N, Yoshida H, Uchida E, Naito Z. Takata H, et al. Oncol Lett. 2016 Dec;12(6):4896-4904. doi: 10.3892/ol.2016.5304. Epub 2016 Oct 21. Oncol Lett. 2016. PMID: 28101228 Free PMC article. - Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women.
Ladd JJ, Busald T, Johnson MM, Zhang Q, Pitteri SJ, Wang H, Brenner DE, Lampe PD, Kucherlapati R, Feng Z, Prentice RL, Hanash SM. Ladd JJ, et al. Cancer Prev Res (Phila). 2012 Apr;5(4):655-64. doi: 10.1158/1940-6207.CAPR-11-0412. Epub 2012 Jan 25. Cancer Prev Res (Phila). 2012. PMID: 22277732 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous